The trademark application DETECT .DISCOVER. IDENTIFY. was filed by BioVentures Inc., a U.S. corporation (the "Applicant"). Application refused.
The application was filed in English (Italian was selected as the second language).
Change of name and address of the trademark registration was recorded on January 20, 2010.
The Refusal with reference B 002972685 was Rejected according to Article 7(1)(b) CTMR with decision issued on January 27, 2005 by the EUIPO.
Goods And Services
The mark was filed in class 1 with Reagents for use in genetic, medical and scientific analysis and research, namely analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, haplotypes and heterozygosity and for use in identifying diseases, assays and kits comprised primarily of reagents, with or without reagent carriers, for use in genetic, medical and scientific analysis and research for analyzing, detecting, quantifying and sequencing polypeptipes and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, haplotyes and heterozygosity and for use in identifying diseases.
The mark was filed in class 9 with Computer programs, computer software for use in genetic, medical and scientific analysis and research, namely for use in analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, haplotypes and heterozygosity and for use in identifying diseases.
The mark was filed in class 42 with Chemical analysis of biochemicals, services for analyzing, detecting, quantifying and sequencing polypeptides and polynucleotides, including polypeptide variants, polynucleotide variants, genetic mutations, single nucleotide polymorphisms, haplotypes and heterozygosity, and services identifying diseases and services designing biological molecules, including polynucleotides, polypeptides and vectors, services evaluating biological molecules, including polynucleotides, polypeptides and vectors, services producing biological molecules, including polynucleotides, polypeptides and vectors, pharmaceutical drug development services for others, drug development services for others, namely evaluating the activity of drugs and candidate substances for drugs, services designing drugs..